Kirtishri Mishra, MD
Urology · New York, NYNPI 1962895433
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (39.4%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 12 manufacturers reported payments, led by Aroa Biosurgery Incorporated at 58.0% of the total. Reporting peaked in 2024 at $11,296 and has fallen 81.9% since, to $2,042 in 2025.
Across 101 payments — averaging $170.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Aroa Biosurgery Incorporated$10K
- Coloplast$3K
- Kerecis Limited$2K
- Boston Scientific$2K
- Integra Lifesciences Corporation$290
- Urogen Pharma, Inc.$173
- plus $265 from 6 others
Across 1 payment — averaging $15,000 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Coloplast$15K
What the payments were for
- Consulting fees$2,80016%
- Speaking & faculty fees$6,80039%
- Travel & lodging$2,83916%
- Food & beverage$4,72027%
- Education$911%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Aroa Biosurgery Incorporated | 12 | $10,002 |
| Coloplast | 45 | $2,946 |
| Kerecis Limited | 5 | $1,907 |
| Boston Scientific | 27 | $1,666 |
| Integra Lifesciences Corporation | 2 | $290 |
| Urogen Pharma, Inc. | 2 | $173 |
| Biotissue Holdings Inc. | 1 | $124 |
| Axonics, Inc. | 2 | $41 |
| Endo Pharmaceuticals Inc. | 2 | $39 |
| Conmed Corporation | 1 | $27 |
| Endo USA, Inc. | 1 | $18 |
| Sumitomo Pharma America, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Kerecis SurgiClose$5,070
- TITAN$2,044
- Kerecis Omega3 SurgiClose$1,424
- Kerecis GraftGuide$1,268
- Kerecis Omega3 Marigen$959
- INTEGRA$633
- Kerecis Omega3 GraftGuide$431
- AMS 700 CXR RTE KIT$418
- INTEGRA DERMAL REGENERATION TEMPLATE$171
- PRIMATRIX$171
- NEOX$124
- CLARIX$124
- CONTOUR$109
- JELMYTO$104
How this compares
$17,249 in reported general payments places this provider in the 85th percentile of 952 urology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxybutynin Chloride ErOxybutynin Chloride | 28 | $739 |
| Trospium Chloride | 13 | $529 |
| Tamsulosin Hcl | 49 | $486 |
| Ciprofloxacin Hcl | 14 | $118 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 14 | $67 |
Paid to pharmacies, not to this prescriber.
Other urology in New York
- Bilal ChughtaiNew York$658K
- Katie MurrayNew York$575K
- Neil BanderNew York$544K
- Robert ValenzuelaNew York$494K
- Kyrollis AttallaNew York$381K
- Benjamin BruckerNew York$364K
- Ketan BadaniNew York$285K
- Michael GrassoNew York$284K
- Mantu GuptaNew York$229K
- Robin SmithNew York$215K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.